Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Z Ke

Showing results (81-90 of 115) with videos related to

Pageof 12
Sort By:
Journal of Musculoskeletal & Neuronal Interactions|March 11, 2005
The role of estrogen receptor-beta, in the early age-related bone gain and later age-related bone loss in female miceH Z Ke, T A Brown, H Qi, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 1, 1994
Effect of cyclosporin A on bone mineral metabolism in experimental diabetes mellitus in the ratS Epstein, M Takizawa, B Stein, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 1, 1992
Prostaglandin E2 alleviates cyclosporin A-induced bone loss in the ratI A Katz, W S Jee, I I Joffe, et al.
Bone|January 23, 1999
Droloxifene does not blunt bone anabolic effects of prostaglandin E2, but maintains prostaglandin E2-restored bone in aged, ovariectomized ratsH Z Ke, D T Crawford, H Qi, et al.
The Journal of Biological Chemistry|June 5, 1998
Cloning and characterization of a novel member of the transforming growth factor-beta/bone morphogenetic protein familyV M Paralkar, A L Vail, W A Grasser, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|May 18, 2026
[Analysis on prediction and mediating effects of triglyceride-glucose body mass index on stroke incidence based on cohort study]Y Liu, X N Ruan, J J Gao, et al.
Bone|October 1, 1995
Droloxifene inhibits cortical bone turnover associated with estrogen deficiency in ratsH K Chen, H Z Ke, C H Lin, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|July 21, 2016
Mice with sclerostin gene deletion are resistant to the severe sublesional bone loss induced by spinal cord injuryW Qin, W Zhao, X Li, et al.
Bone|January 1, 1997
Comparative effects of droloxifene, tamoxifen, and estrogen on bone, serum cholesterol, and uterine histology in the ovariectomized rat modelH Z Ke, H K Chen, H A Simmons, et al.
Bone|August 6, 2014
Temporal changes in systemic and local expression of bone turnover markers during six months of sclerostin antibody administration to ovariectomized ratsMarina Stolina, Denise Dwyer, Qing-Tian Niu, et al.
Pageof 12

Showing results (81-90 of 115) with videos related to

Sort By:
Pageof 12
Journal of Musculoskeletal & Neuronal Interactions|March 11, 2005
The role of estrogen receptor-beta, in the early age-related bone gain and later age-related bone loss in female miceH Z Ke, T A Brown, H Qi, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 1, 1994
Effect of cyclosporin A on bone mineral metabolism in experimental diabetes mellitus in the ratS Epstein, M Takizawa, B Stein, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 1, 1992
Prostaglandin E2 alleviates cyclosporin A-induced bone loss in the ratI A Katz, W S Jee, I I Joffe, et al.
Bone|January 23, 1999
Droloxifene does not blunt bone anabolic effects of prostaglandin E2, but maintains prostaglandin E2-restored bone in aged, ovariectomized ratsH Z Ke, D T Crawford, H Qi, et al.
The Journal of Biological Chemistry|June 5, 1998
Cloning and characterization of a novel member of the transforming growth factor-beta/bone morphogenetic protein familyV M Paralkar, A L Vail, W A Grasser, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|May 18, 2026
[Analysis on prediction and mediating effects of triglyceride-glucose body mass index on stroke incidence based on cohort study]Y Liu, X N Ruan, J J Gao, et al.
Bone|October 1, 1995
Droloxifene inhibits cortical bone turnover associated with estrogen deficiency in ratsH K Chen, H Z Ke, C H Lin, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|July 21, 2016
Mice with sclerostin gene deletion are resistant to the severe sublesional bone loss induced by spinal cord injuryW Qin, W Zhao, X Li, et al.
Bone|January 1, 1997
Comparative effects of droloxifene, tamoxifen, and estrogen on bone, serum cholesterol, and uterine histology in the ovariectomized rat modelH Z Ke, H K Chen, H A Simmons, et al.
Bone|August 6, 2014
Temporal changes in systemic and local expression of bone turnover markers during six months of sclerostin antibody administration to ovariectomized ratsMarina Stolina, Denise Dwyer, Qing-Tian Niu, et al.
Pageof 12